FindTrial
Sign In

Role of alpha blocker and steroid in better and early clearance of kidney and ureteric stones after extracorporeal lithotripsy

Comparison of efficacy of tamsulosin with or without deflazacort vs no treatment in clearance of renal or ureteric calculus after extracorporeal shock wave lithotripsy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/04/013187
Enrollment
135
Registered
2018-04-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- PATIENTS WITH RENAL AND URETERIC CALCULUS SEEKING ELECTIVE PROCEDURE

Interventions

Intervention1: ESWL: EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY Intervention2: ESWL FOR RENAL AND URETERIC CALCULUS: ESWL TO BE REPEATED EVERY 10TH DAY MAXIMUM OF 6 SESSION Control Intervention1: TAMSULOSI

Sponsors

SIR GANGA RAM HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Renal or ureteric calculi proved on plain kidney, ureter, and bladder (KUB) radiography and ultrasonography of the kidney and confirmed with intravenous urogram or CT scan 2. Size between 6 to 15 mm in major axis. 3. Solitary renal / ureteric calculus

Exclusion criteria

Exclusion criteria: 1. History of urinary tract surgery or endoscopic treatment 2. History of Concomitant treatment with alpha blockers, calcium channel blockers, or steroids 3. Morbid obesity (BMI >30) 4. History of previous failed ESWL 5. Patients with diabetes mellitus and hypertension 6. Active Urinary tract infection 7. Uncorrected Coagulopathy 8. Pregnant patient

Design outcomes

Primary

MeasureTime frame
1. To evaluate the efficacy of tamsulosin with or without deflazacort vs no treatment in terms of expulsion rate and expulsion time of stone fragments in renal or ureteric calculus after ESWL. 2. To evaluate the effect of tamsulosin with or without deflazacort administration on frequency of analgesic use for relief of ureteric colic in renal or ureteric calculus after ESWL. Timepoint: Patients will be assessed after every 10 days upto maximum of 60 days—

Secondary

MeasureTime frame
To evaluate the effect of tamsulosin with or without deflazacort administration on frequency of analgesic use for relief of ureteric colic in renal or ureteric calculus after ESWL. Timepoint: Patients will be assessed after every 10 days upto maximum of 60 days—

Countries

India

Contacts

Public ContactDR SAURABH JAIN

SIR GANGA RAM HOSPITAL

docmanu@rediffmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026